Wolfe Research analyst Alexandria Hammond initiated coverage of Biogen (BIIB) with a Peer Perform rating.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BIIB:
- Raymond James sees EU Leqembi uptake as more modest for Biogen than in U.S.
- Eisai receives positive CHMP opinion for Lecanemab in early Alzheimer’s disease
- EMA recommends Leqembi for treatment of early Alzheimer’s disease
- Biogen up 5% after EMA recommends Leqembi for early Alzheimer’s disease
- American upgraded, Regeneron initiated: Wall Street’s top analyst calls